OTC Market Forecast Upgraded

January 2007 | Product Launch

BMI has upwardly revised its projections for the Hungarian over-the-counter (OTC) market after the Health Ministry released the list of medicines that are allowed to be sold outside pharmacies. From the current valuation of US$400mn, we are now expecting sales of OTC products to reach US$690mn by 2010, up significantly from our previous forecast of US$600mn. This represents 15% year-on-year growth, a steeper trajectory than what BMI is expecting for the prescription drug market. However, we caution that Hungary's OTC market has a long way to go before it becomes fully developed like the UK, which offers advanced products like

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.